Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline Post-Exposure Prophylaxis for TBRF
NCT00237016Phase 3Completed
- Sponsor
- Israel Defense Forces Medical Corps
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxycycline in Tick-borne relapsing fever (TBRF), sponsored by Israel Defense Forces Medical Corps. Started Apr 2002; status: completed.
02
Drugs
doxycycline
03
Conditions
Tick-borne relapsing fever (TBRF)
Beyond the preview
Go deeper on NCT00237016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237016.